Dr. Alessandra Bolino, Ospedale San Raffaele, Milan, Italy
Molecular Pathways Targets for CMT4B1
The Muscular Dystrophy Association and CMT Research Foundation announced joint funding for a study by Alessandra Bolino, PhD, at San Raffaele Hospital (Ospedale San Raffaele), Italy, that targets CMT4B1. This project will explore targets in the molecular pathways implicated by CMT4B1. This work has the potential to positively impact several other forms of CMT that are characterized by myelin outfoldings, including CMT4B2, CMT4B3, CMT4C, and CMT4H.
Collaborating with like-minded organizations to fund research that may lead to increasing advancements in treatments and cures for Charcot-Marie-Tooth disease will increase our efficiency and help accelerate MDA’s overall mission to improve the lives of neuromuscular disease patients.